ASAM level of care criteria and Milliman MCG guidelines both drive prior authorization decisions, but payers apply them in distinctly different scenarios. MCG primarily addresses general medical and surgical services, while ASAM specializes in substance use disorder treatment placement. Understanding when payers choose each system can prevent authorization denials and streamline your approval process. The Milliman MCG vs ASAM decision typically depends on the treatment type, with most major payers maintaining separate workflows for each. This guide breaks down exactly when payers rely on MCG versus ASAM criteria and how providers can navigate both systems effectively.
Understanding MCG and ASAM Criteria: Core Differences
What MCG Guidelines Cover
MCG care guidelines function as evidence-based clinical criteria for utilization management across general healthcare services. These guidelines address medical necessity determinations for medical and surgical procedures, inpatient admissions, and length of stay decisions. MCG’s clinical editors analyze peer-reviewed research annually to develop criteria grounded in evidence-based medicine principles [1].
The guidelines serve as decision support for thousands of hospitals and are used by over 80% of the U.S. payer market [2]. MCG provides screening criteria for appropriateness of treatments, location of care, and resource utilization across the care journey. The system has earned URAC accreditation for Health Utilization Management Clinical Review Criteria Certification [1].
For behavioral health, MCG offers separate guidelines built on evidence-based medicine principles. These behavioral health criteria align with and reference multiple organizations, including ASAM, the American Psychiatric Association, and the Level of Care Utilization System (LOCUS) [3]. MCG synthesizes evidence from multiple clinical sources to provide unified decision support [3].
What ASAM Criteria Cover
ASAM criteria establish the standards for placement, continued service, and transfer of patients with addiction and co-occurring conditions. Developed through collaboration that began in the 1980s, ASAM defines national standards for outcome-oriented addiction treatment [4]. The system operates on a continuum from level 0.5 to level 4, with higher numbers indicating more intensive care [4].
The assessment process centers on six core dimensions that inform patient placement:
- Acute intoxication and/or withdrawal potential
- Biomedical conditions and complications
- Emotional, behavioral, and cognitive conditions and complications
- Readiness to change
- Relapse, continued use, or continued problem potential
- Recovery/living environment [5]
This multidimensional biopsychosocial assessment evaluates not only clinical severity but also a patient’s strengths, assets, resources, and support structure [4]. The strength-based approach considers barriers to care, including social determinants of health, patient preferences, and need for motivational enhancement [4]. Assessors use dimensional admission criteria to interpret results and match patients to appropriate intensity levels [4].
Key Distinctions in Scope and Purpose
MCG functions as a broad clinical decision support system spanning medical, surgical, and behavioral health services. The guidelines focus on determining whether specific treatments meet medical necessity standards and establishing appropriate care duration. Payers and managed care organizations utilize MCG to evaluate individual service requests against evidence-based benchmarks [1].
In contrast, ASAM provides specialized criteria exclusively for substance use disorder treatment systems. The framework addresses not just initial placement but ongoing reassessment, with transition and continued service criteria applied throughout recovery [4]. Whereas MCG evaluates discrete medical services, ASAM assesses patients across multiple life dimensions to determine care intensity needs.
The assessment methodologies differ substantially. MCG applies clinical criteria to specific service requests, while ASAM requires comprehensive multidimensional evaluations covering biological, psychological, and social factors [5]. ASAM’s person-centered approach mandates regular reassessment as patients progress, allowing for movement between more or less intensive care levels based on evolving needs [4].
Many states use ASAM as the foundation for addiction treatment system improvements, while MCG serves as the definitive source for general medical necessity decisions [4][1]. Therefore, providers must understand both systems operate independently with distinct evaluation frameworks suited to their respective clinical domains.
When Payers Choose MCG for Medical Necessity Decisions
Utilization review nurses rely on MCG guidelines to match clinical presentations against evidence-based criteria, determining appropriate care settings across the patient journey [6]. This process establishes whether hospital admissions meet medical necessity standards, making services justifiable and reimbursable [6]. Chart documentation must demonstrate the patient’s current condition, explain why outpatient treatment poses safety risks, and outline consequences of denying that care level [6].
General Medical and Surgical Services
Payers turn to MCG when evaluating medical and surgical procedures outside substance use disorder treatment. MCG criteria focus on care pathways and expected recovery timelines, establishing typical treatment courses and timeframes that match most patient profiles [7]. The system identifies situations warranting more intensive or extended care by asking whether the requested service meets accepted medical necessity definitions—meaning the care will likely produce intended results and aligns with current professional standards [7].
Over 80% of the U.S. payer market applies MCG guidelines and software for utilization management decisions [8]. Major payers adopted MCG to navigate complex regulatory requirements while maintaining compliance with healthcare law changes [8]. The guidelines support shared documentation between payers and providers, automating prior authorizations to reduce administrative burden [8].
Acute Care and Hospital Admissions
MCG Hospital Care Guidelines provide screening criteria for proactive inpatient care management, case review, and assessment of patients facing hospitalization or surgery [9]. The guidelines define best-practice care and recovery protocols while supporting efficient resource management [9]. Coverage extends beyond basic admission criteria to include observation care guidelines, behavioral health care with level of care indications, multiple condition management, alternatives to admission, and intensive/intermediate/telemetry care guidelines [9].
Additional decision support covers planning for alternative care settings, hospital and preoperative preparation, safe discharge protocols, common complications, extended length of stay risk factors, assistant surgeon guidelines, optimal pediatric recovery guidelines, neonatal levels of care (I through IV), LTACH guidelines, and hospital-at-home guidelines [9]. MCG tools reduce length of stay in acute settings and decrease 30-day hospital readmissions, improving quality ratings including HEDIS and CMS Stars [8].
Post-Acute Care and Rehabilitation Services
Payers apply MCG criteria for post-acute transitions to skilled nursing facilities, inpatient rehabilitation facilities, and skilled home care [1]. The guidelines facilitate optimal care coordination, including comorbidity management within recovery facilities [1]. For skilled home care, MCG supports well-defined treatment delivery, promotes patient independence, and reduces preventable readmissions [1]. Content includes private duty nursing protocols and comorbidity management strategies [1].
Inpatient rehabilitation facilities face rigorous documentation requirements under CMS regulations. An OIG audit revealed high error rates, with medical records failing to support IRF level of care for 175 of 220 sampled stays [10]. IRF error rates climbed from 9% in 2012 to 62% in 2016 through the Comprehensive Error Rate Testing program [10]. MCG IRF guidelines align with Medicare Benefit Policy Manual requirements, emphasizing that proper documentation remains necessary for medical necessity determinations [10].
Observation vs Inpatient Status Determinations
The distinction between observation and inpatient status creates significant friction between payers and providers [11]. Observation care sits at the center of millions of daily admission decisions, yet definitions vary and implementation remains inconsistent [11]. Database analysis of practice patterns shows observation care is frequently misunderstood and misapplied by clinicians [11].
Under the two-midnight rule established in 2013, inpatient admissions are reasonable and necessary for stays crossing two midnights, payable under Part A [2]. Stays under two midnights generally qualify as outpatient care paid by Part B [2]. However, CMS clarified in 2016 that certain sub-two-midnight stays can receive Part A payment case-by-case based on admitting physician judgment, provided medical records support inpatient necessity subject to review [2].
Hospital-at-home programs gained traction as an alternative acute care model, accelerated by CMS’s Hospitals without Walls initiative in March 2020 [12]. MCG released downloadable Hospital-at-Home guidelines covering cellulitis, chronic obstructive pulmonary disease, heart failure, pneumonia, and urinary tract infection for adult patients [12]. The 27th edition added COVID-19 and acute viral illness [12].
When Payers Choose ASAM for Substance Use Disorder Treatment
Payers apply ASAM level of care criteria when authorizing all substance use disorder treatment services, relying on the system’s standardized assessment framework to determine appropriate placement. ASAM provides a shared language that facilitates communication between providers and payers, with standardized service authorization request forms organized by dimensional criteria [13]. Utilization review specialists rate patient conditions on a 0-4 scale across the six dimensions, with insurers tallying scores to determine care needs [14]. This process repeats during each concurrent review until discharge, with scores typically decreasing as clients progress from detoxification through less intensive programming [14].
Detoxification and Withdrawal Management (Levels 1-WM to 4-WM)
ASAM matches patient severity along Dimension 1 with five withdrawal management intensities, each designated by the “WM” qualifier [4]. Level 1-WM delivers organized outpatient service in office settings, health facilities, or patient homes through trained clinicians who provide medically supervised evaluation according to predetermined schedules [4]. Level 2-WM requires intensive medical monitoring because patients score 2 and 3 risk ratings, indicating moderate to significant withdrawal risk [4].
Level 3.2-WM, often called social setting detoxification, provides 24-hour supervision and observation with emphasis on peer and social support rather than medical nursing care [4]. In contrast, Level 3.7-WM delivers medically monitored inpatient withdrawal management with 24-hour nursing coverage and physician availability, addressing patients whose withdrawal symptoms require constant medical oversight [4]. Level 4-WM serves patients in severe, potentially life-threatening withdrawal from alcohol, benzodiazepines, or polysubstance use with seizure risk, requiring full acute-care hospital staffing [15].
Residential and Inpatient SUD Treatment (Levels 3.1 to 4)
Level 3.1 provides clinically managed low-intensity residential treatment with at least five hours per week of structured programming in home-like settings [15]. Level 3.5 delivers high-intensity residential services with 24-hour care and intensive clinical services for patients requiring constant oversight [15]. Level 3.7 distinguishes itself through medically monitored intensive inpatient care with round-the-clock nursing services and daily physician assessment [15]. Level 4.0 represents the continuum’s highest intensity, providing 24-hour medical management in acute-care hospital settings with ICU-level nursing and on-site pharmacy, laboratory, and imaging capabilities [15].
Outpatient SUD Programs (Levels 1 and 2.1)
Level 1.0 outpatient services provide fewer than nine hours of structured programming weekly for adults and fewer than six hours for adolescents [5][16]. Level 2.1 intensive outpatient programs deliver nine to 19 hours weekly for adults and six to 19 hours for adolescents, serving as both primary treatment and step-down from residential care [17][16].
Partial Hospitalization and Intensive Outpatient (Levels 2.5 and 2.1)
Level 2.5 partial hospitalization requires at least 20 hours of structured programming weekly, with minimum daily limits of four hours [16]. These programs provide clinically intensive services with direct access to psychiatric, medical, and laboratory resources for patients needing daily monitoring without 24-hour supervision [16].
Medication-Assisted Treatment Authorization
ASAM standardized forms prompt providers to include relevant standard measures such as COWS and CIWA scores for patients experiencing withdrawal [13]. Programs must facilitate access to pharmacotherapy for substance use disorders at all levels, with individuals receiving choice regarding medication use [16]. Continued service forms capture progress summaries and transition planning information throughout treatment [13].
How Major Payers Apply MCG vs ASAM in 2026
Major commercial and government payers have established distinct pathways for applying MCG versus ASAM criteria, with implementation timelines varying across plan types and jurisdictions.
UnitedHealthcare’s Dual Criteria Approach
Optum, UnitedHealthcare’s behavioral health division, adopted ASAM Criteria 4th Edition as the official guideline for substance use disorder level of care determinations [18]. Utilization reviewers use ASAM as the clinical benchmark for SUD treatment needs, requiring documentation across all six dimensions in patient assessments to demonstrate medical necessity [18]. For general medical services outside SUD treatment, UnitedHealthcare relies on separate clinical criteria aligned with MCG standards.
Blue Cross Blue Shield Plans and ASAM 4.0 Adoption
Blue Cross Blue Shield entities rolled out ASAM 4.0 implementation on staggered schedules throughout 2025. BCBS Texas announced adoption effective July 1, 2025 for adult substance use services [19]. By comparison, BCBS Illinois and BCBS New Mexico implemented ASAM 4.0 on January 1, 2025 for adults [20] [21]. All BCBS plans continue applying ASAM 3.0 criteria for adolescent populations [19] [20].
Medicaid Managed Care Requirements by State
Twenty-two states require Medicaid plans to use ASAM Criteria for defining or determining medical necessity for SUD benefits [22]. Louisiana Healthcare Connections scheduled transition to ASAM 4.0 evidence-based practice standards for 2026, with providers required to achieve full compliance with revised Medicaid policy criteria by July 1, 2026 [23]. Kentucky became the first state to formally adopt the 4th Edition, effective June 25, 2025 [24]. Until further guidance, Medicaid contracts with Optum in other states remain based on 3rd Edition criteria [24].
Medicare Advantage Plans and MCG Utilization
Medicare Advantage plans predominantly apply MCG guidelines for medical necessity determinations across general healthcare services, maintaining the dual-criteria framework where ASAM addresses SUD treatment while MCG covers medical and surgical authorizations.
Provider Authorization and Documentation Requirements
Authorization workflows differ substantially between MCG and ASAM systems, with each requiring distinct documentation approaches and billing codes.
MCG-Based Prior Authorization Process
MCG AutoAuth delivers automated, evidence-based prior authorization through web-based interfaces integrated into payer portals [25]. Providers document treatment requests and attach relevant care guideline content directly to preauthorization submissions, receiving expedited or immediate responses [25]. The customized rules engine matches payer-specific criteria against clinical information and attached guideline content to authorize procedures or admissions automatically [25]. One health plan client achieved 60% auto-approval rates using MCG Path technology [26]. Providers increased request processing from 3-5 per hour to 12-15, primarily through real-time processing capabilities [26].
ASAM Six-Dimension Assessment Documentation
ASAM requires comprehensive biopsychosocial assessments documenting all six dimensions: acute intoxication/withdrawal potential, biomedical conditions, emotional/behavioral/cognitive conditions, readiness to change, relapse potential, and recovery environment [27]. Providers must include objective evidence such as drug test results, withdrawal scale scores (COWS, CIWA), and treatment history when requesting authorization. Documentation should use ASAM criteria language explicitly, referencing specific dimensional risks that justify the requested level of care.
Billing Codes Specific to Each Criteria System
Medicare established bundled payment codes for opioid treatment programs effective January 2020, with weekly billing thresholds requiring at least one service delivery [3]. HCPCS code G2076 covers initial assessments, while G2077 addresses periodic assessments [3]. For medication-assisted treatment, H0033 designates oral medication administration with direct observation [28]. Place of service codes distinguish treatment settings: POS 22 for partial hospitalization, POS 57 for non-residential facilities, and POS 55 for residential programs.
Common Denial Reasons and Appeal Strategies
Medical necessity denials stem primarily from inadequate documentation, missing prior authorization, incorrect coding, and out-of-network providers [29]. According to AHIMA, 60% of denials remain unworked despite two-thirds being recoverable [29]. Successful appeals require peer-to-peer review requests with medical directors, presenting dimensional evidence supporting continued care necessity. Response times typically range from 24-72 hours for non-urgent requests [30].
Conclusion
The MCG versus ASAM decision boils down to treatment type. Payers consistently apply MCG for medical and surgical services, hospital admissions, and post-acute care. ASAM criteria guide all substance use disorder treatment authorizations, from detoxification through outpatient programs.
Providers face distinct documentation requirements for each system. MCG requires evidence-based clinical justification for specific procedures, while ASAM demands comprehensive six-dimension assessments. Understanding which criteria your payer applies to each service request prevents unnecessary denials and speeds approval times.
Most major payers maintain separate workflows for both systems. Verify your specific plan’s requirements before submitting authorization requests to ensure compliance with the correct criteria framework.
References
[1] – https://www.mcg.com/solutions/care-guidelines/post-acute-care/
[2] – https://www.ama-assn.org/sites/ama-assn.org/files/corp/media-browser/public/about-ama/councils/Council Reports/council-on-medical-service/issue-brief-inpatient-v-observation-care.pdf
[3] – https://www.asam.org/docs/default-source/advocacy/letters-and-comments/section-ii-g-table.pdf?sfvrsn=903d4fc2_2
[4] – https://www.carelonbehavioralhealth.com/content/dam/digital/carelon/cbh-assets/documents/tx/asam-criteria.pdf
[5] – https://www.pyramid-healthcare.com/service/levels-of-care/
[6] – https://www.mcg.com/blog/utilization-review-medical-necessity/
[7] – https://getsolum.com/glossary/interqual-mcg-criteria-guide
[8] – https://www.wellcare.com/en/georgia/providers/bulletins/medicaid-milliman-clinical-guidelines-mcg-rollout
[9] – https://www.mcg.com/solutions/care-guidelines/hospital-care-guidelines/
[10] – https://www.mcg.com/blog/inpatient-rehabilitation-facilities-irfs/
[11] – https://info.mcg.com/white-paper-observation-vs-inpatient.html
[12] – https://www.mcg.com/blog/determining-appropriateness-hospital-at-home/
[13] – https://www.asam.org/asam-criteria/implementation-tools/service-request-forms
[14] – https://www.dataprobillingservice.com/blog/how-to-use-asam-guidelines-to-get-authorization
[15] – https://behavehealth.com/blog/asam-criteria-levels-of-care-complete-guide
[16] – https://alaska-cloudprd.optum.com/content/dam/ops-alaska/documents/providers/training/2024/SUDSLevelofCareTraining_April.pdf
[17] – https://dhhs.ne.gov/Behavioral Health Service Definitions/Adult Substance Use Disorder Intensive Outpatient Level 2.1.pdf
[18] – https://behavehealth.com/blog/unitedhealth-sud-treatment-asam-billing-guidelines
[19] – https://www.bcbstx.com/provider/education/education/news/2025/5-23-2025-update-behavioral-health-substance-use-criteria-for-um
[20] – https://www.bcbsil.com/provider/education/education-reference/news/2024/10-01-2024-updates-bh-substance-abuse-criteria-for-um
[21] – https://www.bcbsnm.com/provider/education-reference/education/news/2024-news-updates/10-01-2024-updates-bh-substance-abuse-criteria-for-um
[22] – https://www.lac.org/assets/files/Spotlight-on-Medical-Necessity-Criteria-for-Substance-Use-Disorder-Treatment.pdf
[23] – https://www.louisianahealthconnect.com/newsroom/asam-criteria-updates-for-adult-substance-use-services–ib-24-2-2.html
[24] – https://www.naatp.org/resources/blog/asam-criteria-4th-edition-implementation-webinar-summary-key-updates-and-discussion
[25] – https://www.mcg.com/solutions/payers-tpas/autoauth-prior-auth-automation/
[26] – https://www.mcg.com/blog/cms-final-rule-prior-authorization-interoperability/
[27] – https://www.asam.org/asam-criteria/implementation-tools/criteria-intake-assessment-form
[28] – https://www.asam.org/docs/default-source/education-docs/billing-and-coding-for-mat_it-matttrs_8-28-2017.pdf?sfvrsn=3f0640c2_2
[29] – https://www.mcg.com/blog/mitigating-medical-necessity-denials/
[30] – https://behavehealth.com/blog/health-care-service-corporation-hcsc-medical-necessity-criteria-for-addiction-treatment